Business · 30/10/2015Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Industry on Controlled Correspondence Related to Generic Drug Development
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on 'Guidance for Industry on Controlled Correspondence Related to Generic Drug Development' under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →